SQZ Biotechnologies

View the org chart displaying its 17 main executives

Most searched biographies at SQZ Biotechnologies

• Howard Bernstein, Interim Chief Executive Officer and Director
• Marc Elia, Director
• Marc Schegerin, Director

Create your alert
to follow the executive moves at SQZ Biotechnologies.

SQZ Biotechnologies has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by SQZ Biotechnologies

Social media about SQZ Biotechnologies

• SQZ Biotechnologies on Wikipedia, Google News & Yahoo Finance
• SQZ Biotechnologies on LinkedIn, Twitter & YouTube

Contact by email its executives including Howard Bernstein

Call SQZ Biotechnologies at +1 617...

View the org chart

Register to receive your alert

Report an error